Buscar | Bresdel

Leena Shedmake agregó una foto Health
2024-06-28 12:45:03 - Translate -

Dyslexia Treatment Market is driven by Increasing Prevalence of Dyslexia
The Global dyslexia treatment market is estimated to be valued at US$ 7.59 Bn in 2024 and is expected to exhibit a CAGR of 6.4% over the forecast period from 2024 to 2031. The increasing prevalence of dyslexia worldwide along with growing awareness levels regarding learning disabilities are major factors driving the growth of the dyslexia treatment market. Furthermore, the development of novel...

0 Commentarios 0 Acciones 848 Views 0 Vista previa

Please log in to like, share and comment!
Leena Shedmake agregó una foto Health
2024-07-30 11:14:12 - Translate -

Dyslexia Treatment Market is Estimated to Witness High Growth Owing to Advancements
Global dyslexia treatment market is estimated to be valued at USD 7.59 Bn in 2024 and is expected to reach USD 11.74 Bn by 2031, exhibiting a compound annual growth rate (CAGR) of 6.4% from 2024 to 2031. Key TakeawaysKey players operating in the dyslexia treatment market are Pfizer, Inc., Teva Pharmaceutical Industries Ltd., Novartis AG, Jubilant Pharma Limited, GSK plc, Eli...

0 Commentarios 0 Acciones 741 Views 0 Vista previa

Please log in to like, share and comment!
Leena Shedmake agregó una foto Health
2024-09-20 12:34:22 - Translate -

Dyslexia Treatment Market Witness Exponential Growth Due to Advancements in Digital Solutions
Global dyslexia treatment market is estimated to be valued at USD 7.59 Bn in 2024 and is expected to reach USD 11.74 Bn by 2031, exhibiting a compound annual growth rate (CAGR) of 6.4% from 2024 to 2031. Key TakeawaysKey players operating in the dyslexia treatment market are Pfizer, Inc., Teva Pharmaceutical Industries Ltd., Novartis AG, Jubilant Pharma Limited, GSK plc, Eli...

0 Commentarios 0 Acciones 825 Views 0 Vista previa

Please log in to like, share and comment!